Promoters of Strides Arcolab Ltd, who were earlier involved in negotiations for selling the injectables business of the public listed company, are now also looking to sell their own stake and exit the firm in a deal worth Rs 2,920 crore ($540 million), sources told VCCircle.Global pharmaceutical manufacturer Pfizer, which ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
